{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:29Z","timestamp":1786735769537,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Circ"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/bc.bc_36_19","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T19:11:10Z","timestamp":1569870670000},"page":"140","source":"Crossref","is-referenced-by-count":6,"title":["Altered metabolism for neuroprotection provided by mesenchymal stem cells"],"prefix":"10.4103","volume":"5","author":[{"given":"Teng","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2394-8108.268363-1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/sctm.18-0070","article-title":"Commitment to aerobic glycolysis sustains immunosuppression of human mesenchymal stem cells","author":"Liu","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"key-10.4103\/2394-8108.268363-2","doi-asserted-by":"crossref","unstructured":"Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells \u2013 Current trends and future prospective. Biosci Rep 2015;35. pii: e00191.","DOI":"10.1042\/BSR20150025"},{"key":"key-10.4103\/2394-8108.268363-3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0022034509340867","article-title":"Mesenchymal stem cells derived from dental tissues vs.Those from other sources: Their biology and role in regenerative medicine","author":"Huang","year":"2009","journal-title":"J Dent Res"},{"key":"key-10.4103\/2394-8108.268363-4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10616-009-9183-2","article-title":"Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions","author":"Riekstina","year":"2008","journal-title":"Cytotechnology"},{"key":"key-10.4103\/2394-8108.268363-5","first-page":"119","article-title":"Amniotic fluid-derived stem cells as an effective cell source for transplantation therapy in stroke","author":"Diaco","year":"2015","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268363-6","first-page":"124","article-title":"Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury","author":"Wu","year":"2018","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268363-7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmed.2010.02.005","article-title":"Mesenchymal stem cell therapy: Two steps forward, one step back","author":"Ankrum","year":"2010","journal-title":"Trends Mol Med"},{"key":"key-10.4103\/2394-8108.268363-8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: Pathological and therapeutic implications","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"key":"key-10.4103\/2394-8108.268363-9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pneurobio.2017.07.004","article-title":"Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms","author":"Stonesifer","year":"2017","journal-title":"Prog Neurobiol"},{"key":"key-10.4103\/2394-8108.268363-10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study","author":"Connick","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/2394-8108.268363-11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/14653249.2011.613929","article-title":"Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: A long-term safety study","author":"Mazzini","year":"2012","journal-title":"Cytotherapy"},{"key":"key-10.4103\/2394-8108.268363-12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Clinical trials with mesenchymal stem cells: An update","author":"Squillaro","year":"2016","journal-title":"Cell Transplant"},{"key":"key-10.4103\/2394-8108.268363-13","first-page":"72","article-title":"Chromatin remodeling protein SMAR1 is a critical regulator of T helper cell differentiation and inflammatory diseases","author":"Mirlekar","year":"2017","journal-title":"Front Immunol"},{"key":"key-10.4103\/2394-8108.268363-14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/btpr.2034","article-title":"Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application","author":"Liu","year":"2015","journal-title":"Biotechnol Prog"},{"key":"key-10.4103\/2394-8108.268363-15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/stem.2510","article-title":"Metabolic reconfiguration supports reacquisition of primitive phenotype in human mesenchymal stem cell aggregates","author":"Liu","year":"2017","journal-title":"Stem Cells"},{"key":"key-10.4103\/2394-8108.268363-16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/mt.2011.189","article-title":"Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation","author":"Fran\u00e7ois","year":"2012","journal-title":"Mol Ther"},{"key":"key-10.4103\/2394-8108.268363-17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.leu.2403871","article-title":"Mesenchymal stem cells induce apoptosis of activated T cells","author":"Plumas","year":"2005","journal-title":"Leukemia"},{"key":"key-10.4103\/2394-8108.268363-18","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","article-title":"Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression","author":"Ren","year":"2009","journal-title":"Stem Cells"},{"key":"key-10.4103\/2394-8108.268363-19","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"key-10.4103\/2394-8108.268363-20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"key-10.4103\/2394-8108.268363-21","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/stem.1986","article-title":"PI3k\u03b1 and STAT1 interplay regulates human mesenchymal stem cell immune polarization","author":"Mounayar","year":"2015","journal-title":"Stem Cells"},{"key":"key-10.4103\/2394-8108.268363-22","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1074\/jbc.M610415200","article-title":"Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: Possible links between cell metabolism and stabilization of HIF","author":"Koivunen","year":"2007","journal-title":"J Biol Chem"},{"key":"key-10.4103\/2394-8108.268363-23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u025b supports the anabolic demands of dendritic cell activation","author":"Everts","year":"2014","journal-title":"Nat Immunol"},{"key":"key-10.4103\/2394-8108.268363-24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"key":"key-10.4103\/2394-8108.268363-25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.clineuro.2012.10.015","article-title":"Stem cell therapy: A clinical trial of stroke","author":"Bhasin","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/2394-8108.268363-26","first-page":"99","article-title":"Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator","author":"Knecht","year":"2018","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268363-27","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.2174\/138161212802002841","article-title":"Permeating the blood brain barrier and abrogating the inflammation in stroke: Implications for stroke therapy","author":"Borlongan","year":"2012","journal-title":"Curr Pharm Des"},{"key":"key-10.4103\/2394-8108.268363-28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11011-012-9283-0","article-title":"The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling","author":"Seifert","year":"2012","journal-title":"Metab Brain Dis"},{"key":"key-10.4103\/2394-8108.268363-29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1089\/scd.2009.0008","article-title":"Inflammation and stem cell migration to the injured brain in higher organisms","author":"Park","year":"2009","journal-title":"Stem Cells Dev"},{"key":"key-10.4103\/2394-8108.268363-30","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/STROKEAHA.115.009854","article-title":"Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke","author":"Acosta","year":"2015","journal-title":"Stroke"},{"key":"key-10.4103\/2394-8108.268363-31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"key-10.4103\/2394-8108.268363-32","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: A phase 1\/2a study","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"key":"key-10.4103\/2394-8108.268363-33","first-page":"128","article-title":"Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion","author":"Kin","year":"2018","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:33:24Z","timestamp":1786732404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_36_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["268363"],"URL":"https:\/\/doi.org\/10.4103\/bc.bc_36_19","relation":{},"ISSN":["2394-8108"],"issn-type":[{"value":"2394-8108","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}